These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27689181)

  • 1. Clinical Data as an Adjunct to Ultrasound Reduces the False-Negative Malignancy Rate in BI-RADS 3 Breast Lesions.
    Ackermann S; Schoenenberger CA; Zanetti-Dällenbach R
    Ultrasound Int Open; 2016 Sep; 2(3):E83-9. PubMed ID: 27689181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound real-time elastography can predict malignancy in BI-RADS®-US 3 lesions.
    Wojcinski S; Boehme E; Farrokh A; Soergel P; Degenhardt F; Hillemanns P
    BMC Cancer; 2013 Mar; 13():159. PubMed ID: 23530903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The negative predictive value of electrical impedance scanning in BI-RADS category IV breast lesions.
    Fuchsjaeger MH; Flöry D; Reiner CS; Rudas M; Riedl CC; Helbich TH
    Invest Radiol; 2005 Jul; 40(7):478-85. PubMed ID: 15973141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI].
    Siegmann KC; Moron HU; Baur A; Hahn M; Vogel U; Claussen CD; Bitzer M
    Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional diagnostic value of MRI in patients with suspicious breast lesions based on ultrasound.
    Sarica O; Uluc F
    Br J Radiol; 2014 Sep; 87(1041):20140009. PubMed ID: 24983629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neddle-guided biopsy in the diagnosis of non-palpable breast cancer].
    Becerra-Alcántara GI; Círigo-Villagómez LL; Ramos-Medina F; Robledo-Martínez H; Mar-Merinos CG; Panzi-Altamirano RM
    Ginecol Obstet Mex; 2015 Jul; 83(7):400-7. PubMed ID: 26422910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrasound examination of breast microcalcifications: luxury or necessity?].
    Balu-Maestro C; Chapellier C; Ben Taaritt I; Fournol M
    J Radiol; 2006 Dec; 87(12 Pt 1):1849-58. PubMed ID: 17213769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
    Yao MM; Joe BN; Sickles EA; Lee CS
    Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
    Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal Breast Lesions in Clinical CT Examinations of the Chest: A Retrospective Analysis.
    Krug KB; Houbois C; Grinstein O; Borggrefe J; Puesken M; Hanstein B; Malter W; Maintz D; Hellmich M
    Rofo; 2017 Oct; 189(10):977-989. PubMed ID: 28683503
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications.
    Loving VA; DeMartini WB; Eby PR; Gutierrez RL; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2010 Dec; 195(6):1472-7. PubMed ID: 21098212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast non-mass-like lesions on contrast-enhanced ultrasonography: Feature analysis, breast image reporting and data system classification assessment.
    Xu P; Yang M; Liu Y; Li YP; Zhang H; Shao GR
    World J Clin Cases; 2020 Feb; 8(4):700-712. PubMed ID: 32149054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the Setting of Negative Mammogram, Is Additional Breast Ultrasound Necessary for Evaluation of Breast Pain?
    Mema E; Cho E; Ryu YK; Jadeja P; Wynn R; Taback B; Ha R
    Curr Probl Diagn Radiol; 2019; 48(2):117-120. PubMed ID: 29402490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of Short-Term Follow-Up in BI-RADS 3 and 4a Breast Lesions with a Histological Diagnosis of Fibroadenoma at Percutaneous Needle Biopsy.
    Clauser P; Bazzocchi M; Marcon M; Londero V; Zuiani C
    Breast Care (Basel); 2017 Sep; 12(4):238-242. PubMed ID: 29070987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of mammography and ultrasonography and their BI-RADS in detection of breast malignancy.
    Ghaemian N; Haji Ghazi Tehrani N; Nabahati M
    Caspian J Intern Med; 2021; 12(4):573-579. PubMed ID: 34820065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic Characteristics and Pathology Correlation of Breast Imaging Reporting and Data System (BI-RADS) Category 4 Lesions.
    Khan P; Masroor I; Alam MS; Salam A; Ali Y; Khan MS
    Cureus; 2023 Dec; 15(12):e51410. PubMed ID: 38292968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of ultrasound elastography in reducing the number of Breast Imaging Reporting and Data System category 3 lesions on ultrasonography.
    Cho N; Lim J; Moon WK
    Ultrasonography; 2014 Apr; 33(2):98-104. PubMed ID: 24936502
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.